• Skip to primary navigation
  • Skip to main content
25 Years

Health Connective

  • About
  • Services
    • Custom Marcom Tools
    • Digital Surgery Online Portal
    • Streamline Your Product Ordering
  • Our Work
    • Surgical Case Review Portals
    • Online Product Catalog
    • Field-Based Program Tracking System
    • Account Management Dashboard
    • Surgical Device Certification System
    • Internal Resources Website for Marketing Division
    • Co-Branding Dashboard
    • Physician Locators
  • Resources
    • Marcom Insights
    • Development Insights
    • The Health Connective Show
  • Get Started
    • Schedule a Call with Health Connective
    • Our Capabilities
    • Security & Compliance

The Benefits of Clinical Trials in Latin America for Medtech Startups

Aired On: June 17, 2025

Hosted By

Michael Roberts

Scott Zeitzer

Julio Martinez-Clark, co-founder and CEO of contract research organization (CRO) bioaccess® joins hosts Michael Roberts and Scott Zeitzer to discuss why Latin America is a great place for clinical trials for medical devices. Julio explains how both the startup and the patients benefit from studies conducted in Latin America, and what startups should be thinking about as they get ready to begin first-in-human studies.

Add to Your Queue

  • Apple Podcasts
  • Spotify 

Resources

  • bioaccess® website

More Episodes

Increasing Speed to Market For MedTech Startups with Bold Type
November 7, 2023

The Current State of Medtech Startups with Alyssa Huffman & Ted Bird
January 14, 2025

Learn More About the Show

Download Transcript

In this Episode

  • 02:59 The Role of CROs in Clinical Trials
  • 06:03 Benefits of Clinical Trials in Latin America
  • 08:52 Challenges for Startups in Clinical Research
  • 12:13 Perceptions of First-in-Human Trials
  • 14:50 Advice for Startups in MedTech
  • 17:57 Navigating Clinical Trials and Regulations

Quotes From This Episode

It is just hard for a regular patient in a Latin American country to have access to the system and to be treated with dignity. So when you come in as the sponsor of the clinical trial or a CRO that is acting on behalf of the sponsor, offering through the investigator a clinical trial to the patient, they love it. They wanna be part of it because they’re gonna have fast access to a medical innovation, and they’re gonna have fast access to the system.

Julio Martinez-Clark

The FDA is risk averse. So they don’t wanna get involved with these high risk clinical trials. They wanna make sure nothing’s gonna happen to any patient, so they give you all these high requirements. The red tape is extremely high, because everybody wants to protect their jobs.

Julio Martinez-Clark

The key message is there are options in Latin America and not only Latin America, there are countries that are very, very friendly to clinical research at this point. That if you submit something, they’re gonna review it and you’re gonna get a site activated in less than eight weeks, which is a record in the United States right now, is almost impossible. So there are options and there are options even closer to home.

Julio Martinez-Clark
  • About
  • Insights
  • Cookie Policy
  • Privacy Policy
  • Get Started
HIPAA Seal of Compliance
Health Connective

(504) 581-4636
LinkedIn